Contamination Control Strategy in Sterile Manufacturing: A Digital, Risk-Based and Future-Oriented Review

One of the most important aspects of pharmaceutical quality assurance is contamination control in sterile pharmaceutical manufacturing, which has a direct bearing on patient safety and product integrity. In sterile manufacturing, the Contamination Control Strategy (CCS) has become the primary, comprehensive framework that incorporates all contamination prevention, detection, and control procedures. All producers of sterile pharmaceuticals are now required by law to have a documented CCS following the release of the updated EU GMP Annex 1 (2022). This overview charts the entire development of CCS from conventional procedural methods to contemporary, risk-based, digitally connected systems. It compares the old and modern CCS philosophies in an organized manner, analyzes documented case studies of actual industry contamination situations, looks at how media fill (process simulation) is integrated into the CCS framework, describes digital tools such as risk-based contamination models, data trending software, paperless batch record systems, and electronic environmental monitoring systems. Future directions in contamination control are also included in the paper, such as robotics and automation in aseptic processing, artificial intelligence (AI) for predictive monitoring, real-time environmental monitoring systems, and sophisticated isolator technologies. Throughout the article, a total of 28 references are mentioned in exact sequential sequence from industry standards, regulatory guidelines, and peer-reviewed research.